JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRIS

Efficacy of albendazole in giardiasis

Thumbnail
View/Open
EMHJ_2001_7_4-5_787_790.pdf (‎168.8Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Abstract
Albendazole and metronidazole were compared in 68 patients diagnosed positive for giardiasis. Albendazole 1200 mg, one dose was given to 24 patients, albendazole 400 mg twice a day for 3 days was given to 23 patients, and metronidazole 400 mg 3 times a day for 5 days to 21 patients. Response to therapy was monitored by clinical examination and analysis of fresh faecal samples on days 0, 3, 7 and 10. Response to the single dose of albendazole was 55%, to the divided dose of albendazole 70%, and to metronidazole 84%. The results show that albendazole, originally recommended for helminthic infection, can also be used in patients with mixed protozoal infection or for infections resistant to metronidazole
Citation
Baqai, R., Zuberi, S.J., Qureshi, H., Ahmed, W. & Hafiz, S. (‎2001)‎. Efficacy of albendazole in giardiasis. EMHJ - Eastern Mediterranean Health Journal, 7 (‎4-5)‎, 787-790, 2001 https://apps.who.int/iris/handle/10665/119089
Journal
EMHJ - Eastern Mediterranean Health Journal, 7 (‎4-5)‎, 787-790, 2001
Description
787-790
ISSN
1020-3397
Other Identifiers
http://applications.emro.who.int/emhj/0704_5/EMHJ_2001_7_4-5_787_790.pdf
Language
English
Collections
  • EMRO Journal Articles (‎EMHJ)‎
Metadata
Show full item record

Show Statistical Information

View Item 
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item
  • IRIS Home
  • 4. Regional Office for the Eastern Mediterranean
  • EMRO Journal Articles (‎EMHJ)‎
  • View Item

© 2021 WHO